Pharmacopeia

Canonical comparison

Master Compare

Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.

2selected
Comparing 2 of 2 drugs
× ×
Change selection
2 drug columns · use arrows or scrollbar
Field NA VALPROATE
Neurology & Sedation · Neurology & Sedation · Level 3
 CARBAMAZEPINE
Neurology & Sedation · Neurology & Sedation
Mechanism of action

Inhibits catabolism of γamino butyric acid(GABA) and inhibits voltage gated Na channels
- Increased [GABA] in neuronal junctions
- Increased Cl- conductance into neurons
- Neuronal hyperpolarization
- Increased threshold for depolarization
- Increased seizure threshold

Inhibits voltage gate Na channels
- Diffuses intracellularly and becomes
ionized
- Inhibits Na influx and therefore inhibits
depolarization
- Neurons become less excitable
Absorption

100% Oral bioavailability

100% Oral bioavailability
Protein binding

90% Protein binding,

80% Protein binding,
Volume of distribution

Vd 0.4l/kg

Vd 1l/kg
Metabolism

Hepatic β oxidation and conjugation

Hepatic phase 1 and 2
Excretion

Renal

Renal
Half-life

T1/2b 20 hours

T1/2b 24 hours
Class Group

Anticonvulsant

Anticonvulsant
Indications Uses

Anti-convulsant
Epilepsy

Anti-convulsant
Epilepsy
Schizophrenia
Trigeminal neuralgia
Legacy Cicm Level

Level 3

-